Plain-English translation of NCT05594706 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 1 research guide →Researchers are studying a blood marker called anhydroglucitol (or 1,5-AG) that may help measure how many healthy, functioning insulin-producing cells remain in children with type 1 diabetes. The study will look at whether this blood marker reliably reflects the health of these cells over time, from the moment of diagnosis through the first year and beyond. If successful, this measurement could one day help doctors better understand how a child's diabetes is progressing and inform treatment decisions.
In type 1 diabetes, the immune system gradually destroys the pancreas cells that produce insulin. Currently, there is no simple, reliable way to measure how many healthy cells remain. This study exists to test whether anhydroglucitol could be that simple blood test — helping doctors track pancreas health without invasive procedures.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have blood draws at specific visits: at the time of your diabetes diagnosis, four months later, and one year after diagnosis (if newly diagnosed); or at one time point if you have had diabetes for several years. Each visit involves a blood test to measure the anhydroglucitol level. You must continue using your insulin pump and continuous glucose monitor as usual during the study, and keep records of your blood sugar readings. The entire study lasts about one year from your enrollment.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Switzerland